Overview

Study to Test the Efficacy and Safety of Vafidemstat in Adult Borderline Personality Disorder Population

Status:
Recruiting

Trial end date:
2022-12-30

Target enrollment:

Participant gender:

Summary

PORTICO is a Phase IIb study to evaluate the efficacy and safety of vafidemstat in an adult borderline personality disorder (BPD) population.

Phase:

Phase 2

Details

Lead Sponsor:

Oryzon Genomics S.A.